Nature Communications (Nov 2022)

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

  • Alexa Pichet Binette,
  • Nicolai Franzmeier,
  • Nicola Spotorno,
  • Michael Ewers,
  • Matthias Brendel,
  • Davina Biel,
  • Alzheimer’s Disease Neuroimaging Initiative,
  • Olof Strandberg,
  • Shorena Janelidze,
  • Sebastian Palmqvist,
  • Niklas Mattsson-Carlgren,
  • Ruben Smith,
  • Erik Stomrud,
  • Rik Ossenkoppele,
  • Oskar Hansson

DOI
https://doi.org/10.1038/s41467-022-34129-4
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 16

Abstract

Read online

The interplay between amyloid and tau pathology in Alzheimer’s disease is still not well understood. Here, the authors show that amyloid-related increased in soluble p-tau is related to subsequent accumulation of tau aggregates and cognitive decline in early stage of the disease.